[go: up one dir, main page]

MX2010014441A - Diaril ureas para tratar la insuficiencia cardiaca. - Google Patents

Diaril ureas para tratar la insuficiencia cardiaca.

Info

Publication number
MX2010014441A
MX2010014441A MX2010014441A MX2010014441A MX2010014441A MX 2010014441 A MX2010014441 A MX 2010014441A MX 2010014441 A MX2010014441 A MX 2010014441A MX 2010014441 A MX2010014441 A MX 2010014441A MX 2010014441 A MX2010014441 A MX 2010014441A
Authority
MX
Mexico
Prior art keywords
heart failure
treating heart
diaryl ureas
diaryl
urea compound
Prior art date
Application number
MX2010014441A
Other languages
English (en)
Inventor
Pper Barbara Albrecht-Ka
Fer Stefan Scha
Elodie Kienlen
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of MX2010014441A publication Critical patent/MX2010014441A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a composiciones farmacéuticas y combinaciones para tratar, prevenir o gestionar la insuficiencia cardiaca y/o enfermedades relacionadas con la misma, que comprenden al menos un compuesto de diaril urea, opcionalmente combinado con al menos un agente terapéutico adicional. Las combinaciones útiles incluyen, por ejemplo, BAY 43-9006 como un compuesto de diaril urea.
MX2010014441A 2008-06-25 2009-06-18 Diaril ureas para tratar la insuficiencia cardiaca. MX2010014441A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08011471 2008-06-25
PCT/EP2009/004390 WO2009156089A1 (en) 2008-06-25 2009-06-18 Diaryl ureas for treating heart failure

Publications (1)

Publication Number Publication Date
MX2010014441A true MX2010014441A (es) 2011-01-21

Family

ID=41136709

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010014441A MX2010014441A (es) 2008-06-25 2009-06-18 Diaril ureas para tratar la insuficiencia cardiaca.

Country Status (13)

Country Link
US (1) US20110263657A1 (es)
EP (1) EP2293792A1 (es)
JP (1) JP2011525506A (es)
KR (1) KR20110031294A (es)
CN (1) CN102076338A (es)
AU (1) AU2009262599A1 (es)
BR (1) BRPI0914636A2 (es)
CA (1) CA2729050A1 (es)
IL (1) IL209647A0 (es)
MX (1) MX2010014441A (es)
RU (1) RU2011102471A (es)
WO (1) WO2009156089A1 (es)
ZA (1) ZA201009063B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102718703B (zh) * 2011-03-31 2016-09-14 中国医学科学院药物研究所 Gk和ppar双重激动活性的含有二甲基的芳基脲类衍生物
AU2012272898A1 (en) 2011-06-24 2013-04-11 Amgen Inc. TRPM8 antagonists and their use in treatments
WO2012177893A2 (en) 2011-06-24 2012-12-27 Amgen Inc. Trpm8 antagonists and their use in treatments
US8952009B2 (en) 2012-08-06 2015-02-10 Amgen Inc. Chroman derivatives as TRPM8 inhibitors
RU2646454C2 (ru) * 2013-11-12 2018-03-05 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" Способ моделирования алкогольной кардиомиопатии

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2288694T3 (es) * 2003-05-20 2008-01-16 Bayer Pharmaceuticals Corporation Diaril ureas para enfermedades mediadas por el receptor del factor de crecimiento derivado de plaquetas.
KR101139557B1 (ko) * 2003-07-23 2012-04-30 바이엘 파마슈티칼스 코포레이션 질환 및 상태의 치료 및 예방을 위한 플루오로 치환오메가-카르복시아릴 디페닐 우레아
US20090197922A1 (en) * 2006-01-24 2009-08-06 The University Of Chicago Compositions and methods for treating pulmonary hypertension
WO2009092442A1 (en) * 2008-01-23 2009-07-30 Universidad De Barcelona Treatment of portal hypertension and related conditions by combined inhibition of the vegf and pdgf signalling pathways

Also Published As

Publication number Publication date
AU2009262599A1 (en) 2009-12-30
WO2009156089A1 (en) 2009-12-30
IL209647A0 (en) 2011-02-28
BRPI0914636A2 (pt) 2015-10-20
RU2011102471A (ru) 2012-07-27
EP2293792A1 (en) 2011-03-16
ZA201009063B (en) 2012-02-29
CA2729050A1 (en) 2009-12-30
CN102076338A (zh) 2011-05-25
JP2011525506A (ja) 2011-09-22
KR20110031294A (ko) 2011-03-25
US20110263657A1 (en) 2011-10-27

Similar Documents

Publication Publication Date Title
ECSP088429A (es) Diarilureas para el tratamiento de la hipertensión pulmonar
WO2008148074A3 (en) Inhibitors of mtor and methods of treatment using same
WO2011041694A3 (en) Compounds as lysophosphatidic acid receptor antagonists
EP2377849A4 (en) CHEMICAL INHIBITOR OF THE P53 SNAIL BINDING AND PHARMACEUTICAL COMPOSITION FOR TUMOR TREATMENT WITH THE INHIBITOR AS AN ACTIVE SUBSTANCE
WO2012078593A3 (en) Lysophosphatidic acid receptor antagonists and their use in the treatment fibrosis
WO2009129246A3 (en) Compositions and methods for preparing and using same
TN2010000122A1 (en) Compounds and compositions as modulators of gpr119 activity
MX2009009491A (es) Compuestos y composiciones como moduladores de la actividad del gpr119.
WO2010077883A3 (en) Antagonists of lysophosphatidic acid receptors
UA98839C2 (en) N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
IN2012DN02702A (es)
MX2009007345A (es) Compuestos con (fenil sustituido), con restos de propenal, sus derivados, actividad biologica y uso del mismo.
WO2011163648A8 (en) Cns delivery of therapeutic agents
PH12013500919B1 (en) Vasoprotective and cardioprotective antidiabetic therapy
EP2512479A4 (en) METHOD AND COMPOSITIONS FOR TREATING PERIPHERAL VASCULAR DISEASE
TW200745124A (en) Azepinoindole derivatives as pharmaceutical agents
BR112014015568A8 (pt) compostos carbamato de fenila para uso em prevenção ou tratamento de epilepsia
AR047993A1 (es) Composicion farmaceutica que comprende pimobendano
MX2007014920A (es) Politerapia que comprende diarilureas para el tratamiento de enfermedades.
MX2010014441A (es) Diaril ureas para tratar la insuficiencia cardiaca.
WO2008048648A3 (en) Cb1-modulating compounds and their use
WO2010062506A3 (en) Decahydro-1h-indenoquinolinone and decahydro-3h-cyclopentaphenanthridinone cyp17 inhibitors
MA32416B1 (fr) 7-sulfanylmethyl-, 7-sulfinymethyl-et 7-sulfonylmethyl-indoles substitues et leur utilisation
BRPI0920351A2 (pt) composição farmacêutica para prevenção e tratamento de diabetes ou obesidade compreendendo um composto que inibe a atividade de dipeptidil peptidade-iv, e outros agentes antidiabéticos ou antiobesidade como ingredientes ativos
WO2008057313A3 (en) Methods of using e2f2 for the treatment of hypertension

Legal Events

Date Code Title Description
FA Abandonment or withdrawal